It is estimated that 2.3 million people in the UK are living with coronary heart disease (CHD) (ONS 2014a). It is therefore important to have a deeper understanding of the pathophysiology of the condition and an awareness of the complex interplay of contributory factors. Written from the perspective of a student ODP, this article investigates the aetiology, presentation and progression of the disease, and puts CHD into the context of the emerging anaesthetic practitioner's practice.
BernhagenJ., SchoberA.2013MIF antagonism as a therapeutic approach to atherosclerosis In: WeberC., SoehnleinO. (eds) Atherosclerosis treatment and preventionFlorida, CRC Press
2.
BlesseyR.1985Epidemiology, risk factors, and pathophysiology of ischemic heart diseaseJournal of the American Physical Therapy Association65(12) 1796–1805
3.
British National Formulary (BNF)2013 (66) London, BMJ Group
4.
CousinsM., CarrD., HorlockerT., BridenbaughP.2009Neural blockade in clinical anaesthesia and pain medicineLondon, Lippincott Williams and Wilkins
5.
ChechiK., DubeyP., CheemaS.K.2006Endothelial dysfunction and atherosclerosis: Role of dietary fats In: CheemaS.K. (ed) Biochemistry of atherosclerosisCanada, Springer
6.
DongM., GilesW., FelittiV.2004Coronary heart disease: Insights into causal pathways for ischemic heart disease. Adverse childhood experiences studyCirculation: American Heart Association110(13) 1761–66
7.
EwartL.2015Lecture Diabetes delivered by Ewart L on Thursday 26th of February 2015
8.
FleisherL.A., FleischmannK.E., AuerbachA.D.2014ACC/AHA Guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgeryJournal of the American College of Cardiology64(22) 78–137
9.
ForslundA.S., LundbladD., JanssonJ.H.2013Risk factors among people surviving out-of-hospital cardiac arrest and their thoughts about what lifestyle means to them: a mixed methods studyBMC Cardiovascular Disorders 13(62) 62
10.
Framingham Heart Study2015Epidemiological background and design: The Framingham Study Available from: www.framinghamheartstudy.org [Accessed April 2016]
11.
GrimenH., IngstadB.2007Qualitative research In: LaakeP. (eds) Research methodology in the medical and biological sciencesOxford, Elsevier
12.
HaweE.2008Compendium of Health Statistics 2008 19th edOxon, Radcliffe Publishing Ltd
13.
HuetherS., McCanceK.2008Alterations in cardiovascular function In: HuetherS., McCanceK. (eds) Understanding pathophysiologyMissouri, Mosby Elsevier
KoenenR., WeberC.2013Chemokines and their receptors as therapeutic targets in atherosclerosis In: WeberC., SoehnleinO. (eds) Atherosclerosis treatment and preventionFlorida, CRC Press
17.
KovacicS., BakranM.2012Genetic susceptibility to atherosclerosisHindawi: Stroke Research and Treatment2012(362941) 1–5
18.
KumarV., AbbasA., FaustoN., AsterJ.2010Robbins and Cotran Pathologic Basis of Disease8th edPhiladelphia PA, Saunders Elsevier
19.
LibbyP., StromJ.B.2011Atherosclerosis In: LillyL.S. (ed) Pathophysiology of heart disease: A collaborative project of medical students and facultyPhiladelphia, Wolters Kluwer Health and Lippincott Williams and Wilkins
20.
LoucksE.B., AlmeidaN.D., TaylorS.E., MatthewsK.A.2011Childhood family psychosocial environment and coronary heart disease riskPsychosomatic Medicine104(73) 563–71
21.
MatfinG.2009Disorders of blood flow in the systemic circulation In: PorthC.M., MatfinG. (eds) Pathophysiology: Concepts of altered health statesPhiladelphia, Wolters Kluwer Health and Lippincott Williams and Wilkins
22.
Office for National Statistics2012Rates of coronary heart disease for England, Wales and England and Wales 1971–2012 Available from: www.ons.gov.uk [Accessed April 2016]
Office for National Statistics2014b Deaths by selected causes England and Wales separately 2012 Available from: www.ons.gov.uk [Accessed April 2016]
25.
PorthC M.2010Disorders of blood flow and blood pressure In: PorthC.M. (ed) Essentials of pathophysiology: Concepts of altered health statesLondon, Lippincott Williams and Wilkins
26.
SchaeferE.J.2010Introduction to high-density lipoprotein, dyslipidaemia and coronary heart disease In: SchaeferE.J. (ed) High-density lipoprotein, dyslipidaemia and coronary heart diseaseUSA, Springer
27.
SenerE., UstunE., UstunB., SarihasanB.2012Hemodynamic responses and upper airway morbidity following tracheal intubation in patients with hypertension: Conventional laryngoscopy versus an intubating laryngeal mask airwayClinics67(1) 49–54
28.
SplanskyG.L., CoreyD., YangQ.2006The third generation cohort of the national heart, lung and blood institute's Framingham Heart Study: Design, recruitment and initial examinationAmerican Journal of Epidemiology165(11) 1328–35
29.
TwiskJ., SnelJ., KemperH., MechelenW.1998Relation between the longitudinal development of personality characteristics and biological and life style risk factors for coronary heart diseasePsychosomatic Medicine60(3) 372–77
30.
UnalB., CritchleyJ., CapewellS.2004Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000Circulation109(9) 1101–07
31.
UnderwoodJ.C., CrossS.S.2010General and systematic pathologyEdinburgh, Churchill Livingstone Elsevier Ltd
32.
WalkerN., LorimerA.R.2004Coronary heart disease: epidemiology, pathology and diagnosis In: LindsayG., GawA. (eds) Coronary heart disease prevention: A handbook for the healthcare teamLondon, Churchill Livingstone
